This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. It is often employed in the development of compounds targeting central nervous system disorders, including anxiety, depression, and psychosis, due to its structural similarity to piperazine derivatives known for their CNS activity. Additionally, it serves as a building block in the creation of novel therapeutic agents, particularly those interacting with serotonin and dopamine receptors. Its fluorophenyl group enhances binding affinity and metabolic stability, making it valuable in drug discovery and optimization processes. Researchers also explore its potential in designing ligands for receptor studies to better understand neurological pathways and disease mechanisms.